Bibliographic Details
| Title: |
86Y-DOTA0)-D-Phe1-Tyr3-octreotide (SMT487)--a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion. |
| Authors: |
Jamar F; Centre of Nuclear Medicine and Laboratory of Positron Emission Tomography, University of Louvain Medical School, Brussels and Louvain-la-Neuve, UCL 54.30, Avenue Hippocrate, 54, 1200, Brussels, Belgium. francois.jamar@mnuc.ucl.ac.be, Barone R, Mathieu I, Walrand S, Labar D, Carlier P, de Camps J, Schran H, Chen T, Smith MC, Bouterfa H, Valkema R, Krenning EP, Kvols LK, Pauwels S |
| Source: |
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2003 Apr; Vol. 30 (4), pp. 510-8. Date of Electronic Publication: 2003 Feb 12. |
| Publication Type: |
Clinical Trial; Clinical Trial, Phase I; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: |
Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1619-7070 (Print) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
